Zhejiang Jiuzhou Pharmaceutical Hits Day High with Strong 5.65% Surge

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has experienced a notable surge in its stock performance, gaining 5.65% on September 25, 2025. The stock reached an intraday high of CNY 20.26, reflecting a strong day of trading activity. This performance stands in contrast to the China Shanghai Composite, which saw a modest increase of 0.83% on the same day.
Over the past year, Zhejiang Jiuzhou has demonstrated impressive growth, with a remarkable 50.85% increase, significantly outperforming the Shanghai Composite's 34.6% gain. Year-to-date, the stock has risen by 42.25%, while its one-month performance shows a positive trend of 3.18%. However, it is worth noting that the stock has faced challenges over the longer term, with a decline of 45.26% over the past three years.

The company has recently reported positive results after six consecutive quarters of negative performance, highlighting a turnaround in its financial health. Key metrics include a robust operating cash flow of CNY 1,519.92 million and a high dividend payout ratio of 63.98%. With a market capitalization of CNY 16,211 million, Zhejiang Jiuzhou continues to position itself as a significant player in the pharmaceuticals and biotechnology sector.